FGF1 reduces cartilage injury in osteoarthritis via regulating AMPK/Nrf2 pathway

Yun-Xuan Li1, Jun Shu1, Nan-Nan Kou1

  • 1Department of Traumatology, The Second Affiliated Hospital of Kunming Medical University, 374 Dianmian Avenue, Wuhua District, Kunming, 650000, Yunnan, China.

PubMed

Insights

Fibroblast growth factor 1 (FGF1) knockdown shows protective effects against osteoarthritis (OA) by activating AMPK and Nrf2 pathways. This study reveals FGF1

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Orthopedics

Background:

  • Osteoarthritis (OA) is a degenerative joint disease influenced by cytokines and growth factors.
  • Fibroblast growth factor 1 (FGF1) role in OA pathogenesis requires further elucidation.
  • Oxidative stress and specific molecular pathways are implicated in OA cartilage destruction.

Purpose of the Study:

  • To investigate the protective effects of fibroblast growth factor 1 (FGF1) knockdown on osteoarthritis.
  • To elucidate the underlying molecular mechanisms of FGF1's involvement in OA.
  • To evaluate the in vivo efficacy of FGF1 modulation in OA models.

Main Methods:

  • In vitro studies involving FGF1 knockdown in chondrocytes.
  • In vivo evaluation using destabilization of the medial meniscus (DMM) and anterior/posterior cruciate ligament transection models.
  • Analysis of protein expression (Nrf2, HO-1) and phosphorylation (AMPK).
  • Knockdown experiments targeting Nrf2 and AMPK to assess their roles.

Main Results:

  • FGF1 knockdown reversed oxidative damage in osteoarthritis models.
  • FGF1 knockdown increased protein expression of Nrf2 and HO-1, linked to AMPK phosphorylation.
  • Nrf2 knockdown abolished the antioxidant effects of FGF1 knockdown on chondrocytes.
  • AMPK knockdown negated the protective impact of FGF1 knockdown in OA.

Conclusions:

  • FGF1 knockdown demonstrates a significant protective effect against osteoarthritis.
  • The mechanism involves the activation of AMPK and Nrf2 pathways in articular chondrocytes.
  • Targeting FGF1 offers a potential therapeutic strategy for preventing and reversing OA.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.5K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.0K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.7K